Last €13.96 EUR
Change Today +0.62 / 4.67%
Volume 50.0
AB3A On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:54 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sandesh Mahatme LL.M.

Chief Financial Officer, Chief Accounting Officer and Senior Vice President, Sarepta Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 2 different industries.

See Board Relationships
49$3,879,070
As of Fiscal Year 2013

Background*

Mr. Sandesh Mahatme, also known as Sandy, LL.M., has been the Chief Financial Officer and Senior Vice President of Sarepta Therapeutics, Inc. since November 5, 2012 and Chief Accounting Officer since October 4, 2013. Prior to Sarepta, Mr. Mahatme served in various roles including Senior Vice President of Corporate Development, Corporate Treasurer and Senior Vice President of Tax at Celgene Corporation since 2006. While at Celgene, he was instrumental in building Celgene's ...

Read Full Background

Corporate Headquarters*

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 857-242-3700
Fax: --

Board Members Memberships*

2014-Present
Director and Chairman of Audit Committee

Education*

Master's Degree
Cornell University School of Law
Master's Degree
New York University School Of Law

Other Affiliations*

Annual Compensation*

Salary$427,167
Bonus$30,000
Total Annual Compensation$457,167

Stock Options*

All Other Compensation$78,523
Exercisable Options67,708
Unexercisable Options249,792
Total Number of Options385,000

Total Compensation*

Total Annual Cash Compensation$749,635
Total Short Term Compensation$457,167
Other Long Term Compensation$78,523
Total Calculated Compensation$3,879,070
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AB3A:GR €13.96 EUR +0.62

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
William A. Carter M.D.Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee
Hemispherx Biopharma, Inc.
$1.0M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
$550.0K
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAREPTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.